SMS Pharmaceuticals Limited has informed the Exchange regarding Re-Appointment of Mr. Vamsi Krishna Potluri as Executive Director of the company w.e.f. July 01, 2025.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has re-appointed Mr. Vamsi Krishna Potluri as Whole Time Director designated as Executive Director for a further period of 3 years, from July 1, 2025 to June 30, 2028. The re-appointment is subject to shareholder approval at the next general meeting. Mr. Vamsi Krishna, who holds degrees from BITS Pilani (Dubai) and Missouri University of Science and Technology, joined the company in 2014 and currently leads the marketing division and R&D operations. He is the eldest son of Mr. Ramesh Babu Potluri (Chairman and Managing Director) and brother of Mr. Trilok Potluri (Non-Executive Director), making this a continuation of promoter family leadership at the company.
This is a routine re-appointment that ensures continuity in the company's executive leadership. Shareholders will need to approve the re-appointment at the upcoming general meeting. No immediate material impact on the stock is expected as it is a procedural governance action.